Comparison of 100-day mortality rates associated with i.v. busulfan and cyclophosphamide vs other preparative regimens in allogeneic bone marrow transplantation for chronic myelogenous leukemia: Bayesian sensitivity analyses of confounded treatment and center effects-Reference-Cited by-同舟云学术

Comparison of 100-day mortality rates associated with i.v. busulfan and cyclophosphamide vs other preparative regimens in allogeneic bone marrow transplantation for chronic myelogenous leukemia: Bayesian sensitivity analyses of confounded treatment and center effects

Published:2004-05-03 Issue:12 Volume:33 Page:1191-1199
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Thall P F,Champlin R E,Andersson B S

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1704461.pdf

Reference44 articles.

1. Horowitz MM . Results of allogeneic stem cell transplantation for malignant disorders. In: Hoffman R, Benz Jr EJ, Shattil SJ, Fine B, Cohen H, Silberstein LE, McGlave P (eds). Hematology, Basic Principles and Practice, 3rd edn. Churchill Livingston, New York, NY, 2000; pp 1573–1587.

2. International Bone Marrow Transplant Registry. September 2000.

3. Bushhouse S, Ramsay NK, Pescovitz OH et al. Growth in children following irradiation for bone marrow transplantation. Am J Ped Hematol/Oncol 1989; 11: 134–140.

4. Sanders JE . Bone marrow transplantation for pediatric leukemia. Pediat Ann 1991; 20: 671–676.

5. Liesner RJ, Leiper AD, Hann IM et al. Late effects of intensive treatment for acute myeloid leukemia and myelodysplasia in childhood. J Clin Oncol 1994; 12: 916–924.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bayesian Statistical Methods in Stem Cell Transplantation and Cellular Therapy;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

2. Busulfan dosing algorithm and sampling strategy in stem cell transplantation patients;British Journal of Clinical Pharmacology;2015-07-22

3. Once-daily i.v. BU-based conditioning regimen before allogeneic hematopoietic SCT: a study of influence of GST gene polymorphisms on BU pharmacokinetics and clinical outcomes in Chinese patients;Bone Marrow Transplantation;2015-03-02

4. Regional differences in performance of bone marrow transplantation, care-resource use and outcome for adult T-cell leukaemia in Japan;BMC Health Services Research;2014-08-08

5. Review of therapeutic drug monitoring of anticancer drugs part 1 – Cytotoxics;European Journal of Cancer;2014-08